Cleared Traditional

K222760 - StageOne™ Select Hip Cement Spacer Molds (FDA 510(k) Clearance)

Dec 2022
Decision
106d
Days
Class 2
Risk

K222760 is an FDA 510(k) clearance for the StageOne™ Select Hip Cement Spacer Molds. This device is classified as a Bone Cement, Antibiotic (Class II - Special Controls, product code MBB).

Submitted by Biomet, Inc. (Warsaw, US). The FDA issued a Cleared decision on December 28, 2022, 106 days after receiving the submission on September 13, 2022.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3027.

Submission Details

510(k) Number K222760 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 13, 2022
Decision Date December 28, 2022
Days to Decision 106 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MBB — Bone Cement, Antibiotic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3027